@djc when mitigating costs, we have to worry about moral hazard, we can’t just say the benefit should scale with the costs to the degree people might cause the costs in undesirable ways (so we don’t provide a cash benefit for heroin users, even though the habit is burdensome and costly, while we should pay for opiates for cancer patients). 2/